InvestorsHub Logo

antihama

07/13/18 10:17 AM

#2255 RE: antihama #2253

And 1248 patients is doubled for pan EGFRex20in (i.e. NSCLC plus all other tumors). So from the JTO article, we can surmise ~2500 more patients than we originally thought could use pozi.